108 related articles for article (PubMed ID: 11966191)
21. A proposal for radical changes in the drug-approval process.
Wood AJ
N Engl J Med; 2006 Aug; 355(6):618-23. PubMed ID: 16899784
[No Abstract] [Full Text] [Related]
22. FDA approvals and label changes.
AIDS Patient Care STDS; 2009 Jul; 23(7):578-9. PubMed ID: 19621996
[No Abstract] [Full Text] [Related]
23. FDA notifications. NRTI Emtriva receives FDA approval.
AIDS Alert; 2003 Oct; 18(10):131-2. PubMed ID: 14686301
[TBL] [Abstract][Full Text] [Related]
24. New clinical trials policy at FDA.
Vastag B
Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
[No Abstract] [Full Text] [Related]
25. Drug development process for a product with a primary pediatric indication.
Allen AJ; Michelson D
J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061
[TBL] [Abstract][Full Text] [Related]
26. A look ahead at this year's drug approvals.
Proj Inf Perspect; 2007 Apr; (43):4-7. PubMed ID: 17684824
[No Abstract] [Full Text] [Related]
27. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
[TBL] [Abstract][Full Text] [Related]
28. US FDA approves Emtriva (FTC).
IAPAC Mon; 2003 Aug; 9(8):180. PubMed ID: 14669738
[No Abstract] [Full Text] [Related]
29. The problem of new uses.
Eisenberg RS
Yale J Health Policy Law Ethics; 2005; 5(2):717-39. PubMed ID: 16052897
[No Abstract] [Full Text] [Related]
30. Communicating with the FDA: the "third rail" of a new model for drug development.
Stanski DR; Orloff JJ
J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
[No Abstract] [Full Text] [Related]
31. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
[No Abstract] [Full Text] [Related]
32. Dismissal of investor fraud claim over HIV drug reversed.
AIDS Policy Law; 2008 Nov; 23(12):8. PubMed ID: 19145698
[No Abstract] [Full Text] [Related]
33. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
AIDS Alert; 2006 Jan; 21(1):11-2. PubMed ID: 16470945
[No Abstract] [Full Text] [Related]
34. Indian company seeks US approval for generic AIDS drugs.
Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
[No Abstract] [Full Text] [Related]
35. The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval process.
Roden DM; Temple R
Circulation; 2005 Apr; 111(13):1697-702. PubMed ID: 15811869
[No Abstract] [Full Text] [Related]
36. Drive for drugs leads to baby clinical trials.
Nature; 2006 Mar; 440(7083):406-7. PubMed ID: 16554774
[No Abstract] [Full Text] [Related]
37. To market, to market. The nuts and bolts of prescription drug approval.
Peterson AM
Adv Nurse Pract; 2001 Apr; 9(4):87-90. PubMed ID: 12420443
[No Abstract] [Full Text] [Related]
38. Anti-HIV therapy update.
Proj Inf Perspect; 2002 Mar; (34):4-6. PubMed ID: 12038301
[TBL] [Abstract][Full Text] [Related]
39. PA-457, new kind of antiretroviral: ten-day clinical trial results.
James JS
AIDS Treat News; 2005 Aug; (414):7-8. PubMed ID: 16206398
[TBL] [Abstract][Full Text] [Related]
40. Experimental drug quickly suppresses HIV.
AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15844233
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
